Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-03-08 Mitchell David Chilton VP Global Regulatory & Quality Grant or award · Stock Option (Right to Buy) +25,000 25,000
2016-03-10 Mitchell David Chilton VP Global Regulatory & Quality Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-08-24 Mitchell David Chilton VP Global Regulatory & Quality Purchase +3,575 $17.81 $64K 3,575
2015-08-11 Mitchell David Chilton VP Global Regulatory & Quality Purchase +1,600 $24.36 $39K 1,600
2015-01-11 Mitchell David Chilton VP Global Regulatory & Quality Grant or award · Stock Option (Right to Buy) +35,000 35,000

Page 1 of 1 · 5 trades